Back
Cabaletta Bio 10K Form
Sell
32
CABA
Cabaletta Bio
Last Price:
4.30
Seasonality Move:
104.04%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive CABA News And Ratings
See the #1 stock for the next 7 days that we like better than CABA
CABA Financial Statistics
Sales & Book Value
| Annual Sales: | -- |
|---|---|
| Cash Flow: | $-21.56M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $4.13 |
| Price / Book: | 1.09 |
Profitability
| EPS (TTM): | -1.91000 |
|---|---|
| Net Income (TTM): | $-89.98M |
| Gross Margin: | -- |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Cabaletta Bio Earnings Forecast
Key Cabaletta Bio Financial Ratios
- Per Share Earnings over the last 6 years have been positive in 2 years.
Cabaletta Bio Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | CABA |
| CUSIP: | 12674W |
| Website: | cabalettabio.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
CABA Technical Analysis vs Fundamental Analysis
Sell
32
Cabaletta Bio (CABA)
is a Sell
Is Cabaletta Bio a Buy or a Sell?
-
Cabaletta Bio stock is rated a Sell
The current Cabaletta Bio [CABA] share price is $4.46. The Score for CABA is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.